InceptionR’s Neurocrine Biosciences NBIX Stock Holding History

InceptionR’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,724	Closed	-$812K	–	812
2025 Q4	$812K	Buy	+5,724	New	+$829K	0.23%	165
2025 Q3	–	Sell	-1,910	Closed	-$240K	–	855
2025 Q2	$240K	Buy	+1,910	New	+$219K	0.06%	513
2024 Q3	–	Sell	-5,944	Closed	-$818K	–	801
2024 Q2	$818K	Buy	+5,944	New	+$815K	0.23%	154

Other funds holding NBIX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

InceptionR's NBIX Position: Q1 2026 in Review

InceptionR sold out of Neurocrine Biosciences (NBIX) in Q1 2026, closing a stake of 5,724 shares — an estimated $812K sold.

InceptionR first reported a position in NBIX in Q2 2024 and held it in 3 quarters. The position peaked at $818K in Q2 2024. 694 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

InceptionR reported no remaining Neurocrine Biosciences position as of Q1 2026 after selling out during the quarter.
InceptionR sold 5,724 Neurocrine Biosciences shares in Q1 2026, an estimated $812K.
InceptionR first reported a position in Neurocrine Biosciences in Q2 2024 and held it in 3 quarters.
InceptionR's Neurocrine Biosciences position peaked at $818K in Q2 2024.
694 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on InceptionR's 13F filing for Q1 2026, filed 14 May 2026.